Loading bill breakdown…
Loading bill breakdown…
Sponsored by Sen. Richard J. Durbin (D-IL) · 4 active : 2 Republicans, 2 Democrats
Latest action: Placed on Senate Legislative Calendar under General Orders. Calendar No. 41.
Interagency Patent Coordination and Improvement Act of 2025
This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.
The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.
Members fall into . All 100 senators have enough data to score.
Bars show each input from 0 to 100: ideology gap, scorecard gap, . is the seat’s partisan lean, and shows how much of the input data a score has.
Loading similar votes
Ideology is each member’s score. The cluster low on the chart includes the bill’s 5 sponsor and cosponsors in the Senate: they have already committed, so they score as entrenched.
Not applicable in the Senate. There is not enough similar voting history (weight 0.0 of 5.0 needed), so this input is left out of the score rather than counted as missing.
No similar roll calls in the Senate